J Uriach Y Compania SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:J Uriach Y Compania SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013216
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
J Uriach Y Compania SA (Uriach) is a pharmaceutical company that offers food supplements, cosmetics and OTC products. It also researches, develops and manufactures active ingredients for the pharmaceutical market. Uriach provides antiflatulents, antifungals, mineral supplements and antiplatelet drugs among others. The company offers its products in the form of tablets, powders, capsules, pills, granules, creams and ointments. It also provides contract manufacturing services. Uriach spans its expertise in the development and marketing of generic files for international licensing. It offers products for sleep and relaxation, skin and beauty, energy and sport, irritation and wounds and others. Uriach is headquartered at Barcelona, Spain.

J Uriach Y Compania SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
J Uriach Y Compania SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Palau Pharma Enters Into Agreement With Sensorion To Develop UR-63325 10
Licensing Agreements 12
Uriach Enters into Licensing Agreement with Teikoku Seiyaku for Rupatadine 12
Ahn-Gook Pharm Enters Into Licensing Agreement With Grupo Uriach For Rhinitis Drug 13
Asset Transactions 14
Actavis Acquires Worldwide Rights To Albaconazole From Palau Pharma 14
Palau Pharma Sells UR-65318 To US Pharma Company 15
Draconis Pharma Acquires Drug Discovery Unit Of Palau Pharma 16
Acquisition 17
Galenica Acquires Remaining Stake In Vifor Uriach Pharma From Grupo Uriach 17
J Uriach Y Compania SA – Key Competitors 18
J Uriach Y Compania SA – Key Employees 19
J Uriach Y Compania SA – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
May 11, 2016: Uriach grows by 10% in 2015, reinforcing its status as a reference for financial performance in the pharmaceutical sector 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Key Facts 2
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
J Uriach Y Compania SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
J Uriach Y Compania SA, Deals By Therapy Area, 2011 to YTD 2017 8
J Uriach Y Compania SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Palau Pharma Enters Into Agreement With Sensorion To Develop UR-63325 10
Uriach Enters into Licensing Agreement with Teikoku Seiyaku for Rupatadine 12
Ahn-Gook Pharm Enters Into Licensing Agreement With Grupo Uriach For Rhinitis Drug 13
Actavis Acquires Worldwide Rights To Albaconazole From Palau Pharma 14
Palau Pharma Sells UR-65318 To US Pharma Company 15
Draconis Pharma Acquires Drug Discovery Unit Of Palau Pharma 16
Galenica Acquires Remaining Stake In Vifor Uriach Pharma From Grupo Uriach 17
J Uriach Y Compania SA, Key Competitors 18
J Uriach Y Compania SA, Key Employees 19
J Uriach Y Compania SA, Other Locations 20
J Uriach Y Compania SA, Subsidiaries 20

★海外企業調査レポート[J Uriach Y Compania SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nordic American Tankers Ltd (NAT):石油・ガス:M&Aディール及び事業提携情報
    Summary Nordic American Tankers Limited (NAT) is a tanker company. It transports crude oil through its fleet of double-hull Suezmax tankers. The company operates its vessels on bareboat charters, time charters, and spot charters. NAT’s tankers are capable of carrying high volumes of oil and able to …
  • Cheil Worldwide Inc. (030000):企業の財務・戦略的SWOT分析
    Cheil Worldwide Inc. (030000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Amara Raja Batteries Ltd (AMARAJABAT):企業の財務・戦略的SWOT分析
    Summary Amara Raja Batteries Ltd (Amara Raja) is a manufacturer of lead-acid storage batteries. The company operates through two divisions such as automotive battery and industrial battery division. Its automotive battery division offers two-wheeler batteries, four-wheeler batteries and tubular batt …
  • Vitasoy International Holdings Limited (345):企業の財務・戦略的SWOT分析
    Vitasoy International Holdings Limited (345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Bacardi Limited:企業の戦略・SWOT・財務情報
    Bacardi Limited - Strategy, SWOT and Corporate Finance Report Summary Bacardi Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Solstad Farstad ASA (SOFF):石油・ガス:M&Aディール及び事業提携情報
    Summary Solstad Farstad ASA (Solstad), formerly Solstad Offshore ASA is an oil and gas company that provides vessel operation solutions. The company offers carbon footprint, climate neutral network, offshore shipping, green operations, and rainforest protection, documentation programs, and others. I …
  • Okinawa Cellular Telephone Company (9436):企業の財務・戦略的SWOT分析
    Okinawa Cellular Telephone Company (9436) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • SpringWorks Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary SpringWorks Therapeutics LLC (SpringWorks Therapeutics) is a drug development company that develops therapeutic medicines for various diseases. The company’s pipeline products include Nirogacestat, MEK ½ Inhibitor, Senicapoc and FAAH Inhibitor. Its Nirogacestat is a gamma secretase inhibitor …
  • Siemens Gamesa Renewable Energy SA (SGRE):企業の財務・戦略的SWOT分析
    Siemens Gamesa Renewable Energy SA (SGRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • RainDance Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary RainDance Technologies Inc (RDT) is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA. It also offers RainDrop Plus digital PCR s …
  • Debt Resolve Inc (DRSV):企業の財務・戦略的SWOT分析
    Summary Debt Resolve Inc (Debt Resolve) is a technology company that offers cloud-based software and services. The company develops and markets patent-based web collection technologies. It provides solutions for non-payment of bills, debts, damages and other financial disputes. Debt Resolve also off …
  • Lennox International Inc (LII):企業の財務・戦略的SWOT分析
    Lennox International Inc (LII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Damodar Valley Corporation:企業の戦略的SWOT分析
    Damodar Valley Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Total SA (FP):企業の財務・戦略的SWOT分析
    Total SA (FP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Biovotion AG:医療機器:M&Aディール及び事業提携情報
    Summary Biovotion AG (Biovotion) is a medical device company that offers healthcare monitoring solutions. The company offers Ecosystem, Everion and Augment app. Its Ecosystem is a wearable sensor monitor that consists of data collection, analytics, storage in the cloud and visualization tools used i …
  • Aon plc:企業のM&A・事業提携・投資動向
    Aon plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aon plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Sparton Resources Inc (SRI):企業の財務・戦略的SWOT分析
    Summary Sparton Resources Inc (Sparton Resources) is a diversified company that acquires and develops oil and gas properties in North America and China. The company’s products include vanadium, natural gas, crude oil, gold, and vanadium flow batteries, among others. Its energy projects comprise Sier …
  • MGM Resorts International:企業の戦略・SWOT・財務情報
    MGM Resorts International - Strategy, SWOT and Corporate Finance Report Summary MGM Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Kuwait Petroleum Corp:企業の戦略的SWOT分析
    Kuwait Petroleum Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Alterity Therapeutics Ltd (PBT):企業の財務・戦略的SWOT分析
    Summary Alterity Therapeutics Ltd (Alterity Therapeutics) formerly known as Prana Biotechnology Ltd, is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease, brain cancer and other major age-related degenerative disorders. It is developing …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆